Skip to content

Purdue researcher awarded $1.3 million for malaria drug trials in Southeast Asia and Africa – Purdue University

  • by
  • Asia
Purdue researcher awarded $1.3 million for malaria drug trials in Southeast Asia and Africa – Purdue University

 

Philip Low looks to validate previous trial results and test whether the number of days of an anti-malaria drug therapy can be reducedWEST LAFAYETTE, Ind. – A Purdue researcher is taking a giant leap forward in the fight against drug-resistant strains of malaria in developing countries.Open Philanthropy has awarded $1.38 million to Philip Low to further validate a drug therapy that he and his colleagues have previously shown to successfully treat the disease. Low (rhymes with “now”) is Purdue University’s Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry in the College of Science.For years, experts… 

​ 

Read More 

Leave a Reply

Your email address will not be published. Required fields are marked *